A Phase 1b Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of JNJ-64565111 in Participants With Type 2 Diabetes Mellitus
Clinical trial NCT03235219 · COMPLETED
Trial details
- NCT number
- NCT03235219
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-01
- Primary completion
- 2018-02-19
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.